Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.120
+0.020 (1.82%)
At close: Jul 21, 2025, 4:00 PM
1.110
-0.010 (-0.89%)
After-hours: Jul 21, 2025, 4:27 PM EDT
Rockwell Medical Stock Forecast
Stock Price Forecast
The 2 analysts that cover Rockwell Medical stock have a consensus rating of "Strong Buy" and an average price target of $4, which forecasts a 257.14% increase in the stock price over the next year. The lowest target is $3 and the highest is $5.
Price Target: $4 (+257.14%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 24, 2025.
Analyst Ratings
The average analyst rating for Rockwell Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3 | Strong Buy | Maintains | $7 → $3 | +167.86% | Mar 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +525.00% | Dec 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +525.00% | Nov 25, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +346.43% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +703.57% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
69.59M
from 101.49M
Decreased by -31.43%
Revenue Next Year
77.36M
from 69.59M
Increased by 11.16%
EPS This Year
-0.21
from -0.03
EPS Next Year
-0.15
from -0.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 73.1M | 85.6M |
| Avg | 69.6M | 77.4M |
| Low | 65.5M | 68.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | -28.0% | 23.0% |
| Avg | -31.4% | 11.2% |
| Low | -35.5% | -1.2% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.19 | -0.09 |
| Avg | -0.21 | -0.15 |
| Low | -0.23 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.